Furthermore, B4GALT1 led to the formation of the sialyl-Lewis X determinant, which was used as a tumor marker for lung cancer, but is also expressed by pulmonary epithelial cell in patients with IPF [15,16]. This evidence concerns the gene B4GALT1 and neoplasm.